IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,253,000 | -69.7% | 590,400 | -53.1% | 0.18% | -72.5% |
| Q4 2021 | $10,722,000 | -24.8% | 1,258,400 | -23.3% | 0.64% | -50.0% |
| Q3 2021 | $14,251,000 | +177.8% | 1,639,900 | +237.9% | 1.28% | +141.5% |
| Q2 2021 | $5,130,000 | -34.1% | 485,368 | 0.0% | 0.53% | -32.8% |
| Q1 2021 | $7,785,000 | -3.9% | 485,368 | +110.7% | 0.79% | -23.3% |
| Q3 2020 | $8,105,000 | +155.4% | 230,307 | +76.7% | 1.02% | +32.4% |
| Q2 2020 | $3,173,000 | -64.4% | 130,307 | -77.2% | 0.77% | -37.0% |
| Q1 2020 | $8,902,000 | +460.9% | 571,942 | +471.9% | 1.23% | +429.3% |
| Q4 2019 | $1,587,000 | – | 100,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |